Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Somatroipn

somatroipn · Daewoong Pharmaceutical Co. LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Somatroipn, covering 2016-02-29 to 2016-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency [Phase 3]

See pricing